Bank Of Nova Scotia Biogen Inc. Transaction History

Bank Of Nova Scotia

$52.2 Billion
Q4 2024

A detailed history of Bank Of Nova Scotia transactions in Biogen Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 20,552 shares of BIIB stock, worth $2.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,552

Previous 18,637 10.28%

Holding current value

$2.95 Million

Previous $3.61 Million 13.01%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$146.47 - $191.55 $280,490 - $366,818	1,915 Added 10.28%	20,552 $3.14 Million
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $658,908 - $825,248	3,485 Added 23.0%	18,637 $3.61 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $16.7 Million - $20.8 Million	-87,907 Reduced 85.3%	15,152 $3.51 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $12.1 Million - $15.3 Million	-57,204 Reduced 35.69%	103,059 $22.2 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $29 Million - $34.9 Million	130,169 Added 432.54%	160,263 $41.5 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $4.32 Million - $4.87 Million	17,036 Added 130.46%	30,094 $7.73 Million
Q2 2023 Aug 03, 2023	BUY	$275.25 - $318.06 $479,485 - $554,060	1,742 Added 15.39%	13,058 $3.72 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $493,621 - $562,462	-1,924 Reduced 14.53%	11,316 $3.15 Million
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $315,045 - $382,786	1,248 Added 10.41%	13,240 $3.67 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $20,442 - $28,188	-105 Reduced 0.87%	11,992 $3.2 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $1.61 Million - $1.92 Million	8,607 Added 246.62%	12,097 $2.47 Million
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $2.77 Million - $3.29 Million	-14,764 Reduced 80.88%	3,490 $711,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $2.58 Million - $3.26 Million	-13,333 Reduced 42.21%	18,254 $3.84 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $1.63 Million - $2.1 Million	7,281 Added 29.96%	31,587 $7.58 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $476,555 - $621,480	1,684 Added 7.44%	24,306 $6.88 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $5.86 Million - $9.38 Million	22,622 New	22,622 $7.83 Million

Others Institutions Holding BIIB

# of Institutions

1,001

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Biogen Inc. Transaction History